| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Urogen Pharma Ltd. (URGN) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. URGN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 153.2K | $4.57M | - | |
| Other | 139.0K | $4.14M | - | |
| Other | 55.6K | $1.66M | - | |
| Dir | 20.0K | $596.0K | - | |
| Dir | 6.0K | $178.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2025 | Smith Jason Drew48 | General Counsel | Sale+OE | 7,379 | $11.14 | $82,202.06 | -7.7% | +3.6% | +78.1% | |
| Sep 9, 2024 | Schoenberg Mark60 | Chief Medical Officer | Sale+OE | 859 | $13.08 | $11,235.72 | -0.6% | -8.8% | +55.0% | |
| Sep 9, 2024 | Smith Jason Drew48 | General Counsel | Sale+OE | 1,521 | $13.08 | $19,894.68 | -5.7% | -8.8% | +55.0% | |
| Jun 10, 2024 | Schoenberg Mark60 | Chief Medical Officer | Sale+OE | 5,153 | $13.08 | $67,401.24 | -3.4% | +4.5% | -44.8% | |
| Mar 18, 2024 | Schoenberg Mark60 | Chief Medical Officer | Sell | 12,000 | $14.05 | $168,600.00 | -7.9% | +26.1% | -20.5% | |
| Jan 31, 2024 | Smith Jason Drew48 | General Counsel | Sale+OE | 4,993 | $15.74 | $78,589.82 | -7.4% | -12.0% | -27.7% | |
| Jan 31, 2024 | Schoenberg Mark60 | Chief Medical Officer | Sale+OE | 3,789 | $15.74 | $59,638.86 | -0.8% | -12.0% | -27.7% | |
| Aug 31, 2023 | Smith Jason Drew48 | General Counsel | Sale+OE | 3,800 | $18.01 | $68,438.00 | -17.1% | -26.5% | -20.4% | |
| Jan 31, 2023 | Schoenberg Mark60 | Chief Medical Officer | Sale+OE | 1,900 | $10.12 | $19,228.00 | -0.4% | +37.5% | +51.1% | |
| Jan 31, 2023 | Smith Jason Drew48 | General Counsel | Sale+OE | 1,636 | $10.12 | $16,556.32 | -5.8% | +37.5% | +51.1% |